Clicky

Oric Pharmaceuticals, Inc.(ORIC) News

Date Title
May 8 We Think ORIC Pharmaceuticals (NASDAQ:ORIC) Can Afford To Drive Business Growth
May 6 ORIC Pharmaceuticals Reports First Quarter 2024 Financial Results and Operational Updates
May 3 ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Apr 15 ORIC Pharmaceuticals Announces First Patients Dosed Across Three Expansion Cohorts in Phase 1b Trial of ORIC-114 in Patients with Mutated NSCLC
Apr 8 ORIC Pharmaceuticals Presents Preclinical Data on Two Programs at the 2024 American Association for Cancer Research (AACR) Annual Meeting
Apr 4 ORIC Pharmaceuticals to Participate in Upcoming Investor Conferences
Mar 26 How Much Upside is Left in Oric Pharmaceuticals (ORIC)? Wall Street Analysts Think 39.3%
Mar 13 ORIC Pharmaceuticals Inc (ORIC) Reports Q4 and Full Year 2023 Financial Results
Mar 11 ORIC Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Updates
Mar 8 ORIC Pharmaceuticals Inc CEO Jacob Chacko Sells 40,000 Shares
Mar 6 ORIC Pharmaceuticals to Present at the Leerink Partners Global Biopharma Conference
Mar 5 ORIC Pharmaceuticals Announces Multiple Presentations at the 2024 American Association for Cancer Research (AACR) Annual Meeting
Jan 9 Final Boarding Call: 3 Stocks Set for a Sky-High Surge
Jan 8 ORIC Pharmaceuticals Provides Initial Phase 1b Data for ORIC-944, Operational Highlights for 2023, and Anticipated Upcoming Milestones
Nov 6 ORIC Pharmaceuticals Inc (ORIC) Reports Q3 2023 Financial Results and Operational Updates
Nov 6 ORIC Pharmaceuticals Reports Third Quarter 2023 Financial Results and Operational Updates
Nov 4 Here's Why We're Not Too Worried About ORIC Pharmaceuticals' (NASDAQ:ORIC) Cash Burn Situation
Nov 3 ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Nov 2 ORIC Pharmaceuticals to Present Initial Phase 1b Clinical Data for ORIC-533 in Multiple Myeloma at the 65th American Society of Hematology (ASH) Annual Meeting